Status:
COMPLETED
Clinical Study of 18F-FAPI-RGD in Breast Tumors
Lead Sponsor:
Sichuan Provincial People's Hospital
Conditions:
Breast Tumors
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the value of 18F-FAPI-RGD PET/CT imaging in Breast Tumors. Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.
Detailed Description
Breast cancer is the most common malignant disease in women worldwide.Early detection, accurate diagnosis and staging are the keys to effective treatment for breast cancer patients.18F-FDG PET/CT has ...
Eligibility Criteria
Inclusion
- Age 18 and above
- No gender difference
- Patients who have been diagnosed with, or are clinically highly suspected of, breast tumors and have had no other treatment within 3 months
- Tumor size (T), lymph node status (N), and overall clinical stage of diagnosed patients were determined according to the American Joint Committee on Cancer criteria revised in 2010
Exclusion
- Patients with a second primary tumor
- Pregnant or breastfeeding
- Severe liver or kidney disease
- Claustrophobia or other PET/CT scan contraindications
Key Trial Info
Start Date :
June 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 20 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05976620
Start Date
June 20 2023
End Date
February 20 2024
Last Update
July 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Departments of Nuclear Medicine, Sichuan Provincial People's Hospital
Chengdu, Sichuan, China, 610072